Molecular Imaging: Page 84

Kent Institute opens in U.K. with royal visit, GE equipment

By AuntMinnieEurope.com staff writers

The Duke of Gloucester was guest of honor at the 2 April opening of the U.K.'s Kent Institute of Medicine and Surgery, the city's first tertiary care center that will offer complex procedures and acute care in a broad range of specialties.

April 1, 2014

U.K. issues new guidance on cancer imaging

By Philip Ward

The U.K. Royal College of Radiologists (RCR) has published updated recommendations for cross-sectional imaging in cancer management. They can be downloaded free of charge from the RCR's website.

March 31, 2014

Navidea's PET agent featured at German nuclear medicine congress

By AuntMinnieEurope.com staff writers

Navidea Biopharmaceuticals has announced its PET imaging agent NAV4694 is the subject of several presentations at this week's German Society of Nuclear Medicine annual congress.

March 26, 2014

IBA divests PharmaLogic PET Services

By AuntMinnieEurope.com staff writers

Ion Beam Applications (IBA) has sold the assets of its PharmaLogic PET Services of Montreal subsidiary to a private equity firm.

March 16, 2014

Global nuclear medicine market poised for growth

By AuntMinnieEurope.com staff writers

The global nuclear medicine market will reach $24 billion by 2030 (18 billion euros), with an annual average increase of 11%, according to a new market research report by MEDraysintell.

March 13, 2014

Study finds PET/CT can help diagnose CUP syndrome

By Erik L. Ridley

VIENNA - FDG-PET/CT can identify a possible primary tumor in patients with carcinoma with unknown primary tumor (CUP) syndrome at a rate comparable to that found in autopsy studies, German researchers reported on Monday at ECR 2014.

March 9, 2014

Controversy breaks out over how to study cell death in cancer

By Philip Ward

VIENNA - When Dr. Uwe Haberkorn drew breath after his ECR presentation during a New Horizons session on imaging the hallmarks of cancer, he probably didn't anticipate the lively debate that was to follow.

March 8, 2014

Hybrid imaging gathers momentum in cardiac indications

By Becky McCall

VIENNA - Hybrid imaging is gaining acceptance as opportunities using combinations of modalities emerge and promise to optimize cardiac imaging, according to expert speakers in today's session called "Hybrid cardiovascular imaging: Where should we go?" at ECR 2014.

March 5, 2014

AAA gets orphan drug status, buys private distributor

By AuntMinnieEurope.com staff writers

Advanced Accelerator Applications (AAA) has received orphan drug designation status for gallium-68 DOTATATE.

March 4, 2014

AAA gets orphan drug status

By AuntMinnieEurope.com staff writers

Advanced Accelerator Applications (AAA) has received orphan drug designation status for gallium-68 DOTATATE.

March 4, 2014

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

February 26, 2014

Ga-68 DOTATATE PET/CT detects neuroendocrine tumor recurrence

By Wayne Forrest

German researchers have confirmed the efficacy of PET/CT with the radiopharmaceutical gallium-68 (Ga-68) DOTATATE for detecting the recurrence of neuroendocrine tumors, in a study published in the February issue of Radiology.

February 26, 2014

Previous Page

Page 84 of 122

Next Page